We subsequently used small molecular inhibitors of EGFR (gefitinib), IGF-1R (linsitinib), and CRAF (GW5074), as single agent or in combination to further verify whether these genes really participate in BRAFi resistance in VemR A375 melanoma cells. Here, RAF1 is linked to melanoma.